Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (25) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter Shortages Remove Shortages filter Withdrawn applications (29) Apply Withdrawn applications filter Paediatric investigation plans (26) Apply Paediatric investigation plans filter Orphan designations (27) Apply Orphan designations filter Direct healthcare professional communication (18) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (7) Apply Yes filter

Authorisation status

Authorised (343) Apply Authorised filter Refused (3) Apply Refused filter Withdrawn (65) Apply Withdrawn filter

ATC code

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Negative (2) Apply Negative filter Positive (15) Apply Positive filter

Application type

Initial authorisation (12) Apply Initial authorisation filter Post-authorisation (5) Apply Post-authorisation filter

Referral name

Referral status

European Commission final decision (5) Apply European Commission final decision filter Under evaluation (1) Apply Under evaluation filter

Referral safety status

Yes (3) Apply Yes filter

Referral type

Article 20 procedures (3) Apply Article 20 procedures filter Article 31 referrals (3) Apply Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (3) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (3) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (3) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter Generic Remove Generic filter Accelerated assessment (45) Apply Accelerated assessment filter Additional monitoring (405) Apply Additional monitoring filter Exceptional circumstances (44) Apply Exceptional circumstances filter Orphan medicine (162) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

434 results

Remove all filtersRemove all filters

Medicine Shortages Remove Shortages filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter

Medicine type Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter Generic Remove Generic filter

Categories Human Remove Human filter

Sort by

List item

Human medicine European public assessment report (EPAR): Caprelsa (updated)

Vandetanib, Thyroid Neoplasms
Date of authorisation: 16/02/2012, , , Revision: 22, Authorised, Last updated: 30/06/2022
List item

Human medicine European public assessment report (EPAR): Abiraterone Mylan (updated)

abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 20/08/2021, , Revision: 2, Authorised, Last updated: 30/06/2022
List item

Human medicine European public assessment report (EPAR): Tadalafil Mylan (updated)

tadalafil, Erectile Dysfunction
Date of authorisation: 21/11/2014, , Revision: 14, Authorised, Last updated: 30/06/2022
List item

Human medicine European public assessment report (EPAR): Memantine ratiopharm (updated)

memantine hydrochloride, Alzheimer Disease
Date of authorisation: 12/06/2013, , Revision: 8, Authorised, Last updated: 30/06/2022
List item

Human medicine European public assessment report (EPAR): Ocaliva (updated)

Obeticholic acid, Liver Cirrhosis, Biliary
Date of authorisation: 12/12/2016, , , , Revision: 13, Authorised, Last updated: 30/06/2022
List item

Human medicine European public assessment report (EPAR): Ambrisentan Mylan (updated)

ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/06/2019, , Revision: 3, Authorised, Last updated: 29/06/2022
List item

Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)

CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021, , , , Revision: 24, Authorised, Last updated: 29/06/2022
List item

Human medicine European public assessment report (EPAR): Bemfola (updated)

follitropin alfa, Anovulation
Date of authorisation: 26/03/2014, , Revision: 9, Authorised, Last updated: 28/06/2022
List item

Human medicine European public assessment report (EPAR): Prasugrel Mylan (updated)

prasugrel besilate, Myocardial Infarction; Acute Coronary Syndrome; Angina, Unstable
Date of authorisation: 15/05/2018, , Revision: 8, Authorised, Last updated: 28/06/2022
List item

Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)

sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009, , Revision: 15, Authorised, Last updated: 28/06/2022
List item

Human medicine European public assessment report (EPAR): Rozlytrek (updated)

Entrectinib, Cancer; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 31/07/2020, , , Revision: 4, Authorised, Last updated: 27/06/2022
List item

Human medicine European public assessment report (EPAR): Mycophenolate mofetil Teva (updated)

mycophenolate mofetil, Graft Rejection
Date of authorisation: 21/02/2008, , Revision: 25, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Azacitidine Mylan (updated)

azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 27/03/2020, , Revision: 4, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Levetiracetam Sun (updated)

levetiracetam, Epilepsy
Date of authorisation: 14/12/2011, , Revision: 17, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Accofil (updated)

filgrastim, Neutropenia
Date of authorisation: 17/09/2014, , Revision: 13, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Sapropterin Dipharma (updated)

Sapropterin dihydrochloride, Phenylketonurias
Date of authorisation: 16/02/2022, , Revision: 1, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Desloratadine ratiopharm (updated)

desloratadine, Rhinitis, Allergic, Perennial; Urticaria; Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012, , Revision: 12, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Zoledronic acid Mylan (updated)

zoledronic acid, Fractures, Bone
Date of authorisation: 23/08/2012, , Revision: 13, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Sildenafil ratiopharm (updated)

sildenafil, Erectile Dysfunction
Date of authorisation: 23/12/2009, , Revision: 19, Authorised, Last updated: 24/06/2022
List item

Human medicine European public assessment report (EPAR): Imatinib Accord (updated)

imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome
Date of authorisation: 30/06/2013, , Revision: 23, Authorised, Last updated: 23/06/2022
List item

Human medicine European public assessment report (EPAR): Myfenax (updated)

mycophenolate mofetil, Graft Rejection
Date of authorisation: 21/02/2008, , Revision: 26, Authorised, Last updated: 23/06/2022
List item

Human medicine European public assessment report (EPAR): Lunsumio (updated)

mosunetuzumab, Lymphoma, Follicular
Date of authorisation: 03/06/2022, , , , Authorised, Last updated: 23/06/2022
List item

Human medicine European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan (updated)

sitagliptin hydrochloride monohydrate, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 16/02/2022, , Revision: 1, Authorised, Last updated: 21/06/2022
List item

Human medicine European public assessment report (EPAR): Carvykti (updated)

ciltacabtagene autoleucel, Multiple Myeloma
Date of authorisation: 25/05/2022, , , , Authorised, Last updated: 17/06/2022
List item

Human medicine European public assessment report (EPAR): Dimethyl fumarate Polpharma (updated)

dimethyl fumarate, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 13/05/2022, , Revision: 01, Authorised, Last updated: 17/06/2022

Load more

434 results

Human medicine European public assessment report (EPAR): Caprelsa (updated)

Human medicine European public assessment report (EPAR): Abiraterone Mylan (updated)

Human medicine European public assessment report (EPAR): Tadalafil Mylan (updated)

Human medicine European public assessment report (EPAR): Memantine ratiopharm (updated)

Human medicine European public assessment report (EPAR): Ocaliva (updated)

Human medicine European public assessment report (EPAR): Ambrisentan Mylan (updated)

Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)

Human medicine European public assessment report (EPAR): Bemfola (updated)

Human medicine European public assessment report (EPAR): Prasugrel Mylan (updated)

Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)

Human medicine European public assessment report (EPAR): Rozlytrek (updated)

Human medicine European public assessment report (EPAR): Mycophenolate mofetil Teva (updated)

Human medicine European public assessment report (EPAR): Azacitidine Mylan (updated)

Human medicine European public assessment report (EPAR): Levetiracetam Sun (updated)

Human medicine European public assessment report (EPAR): Accofil (updated)

Human medicine European public assessment report (EPAR): Sapropterin Dipharma (updated)

Human medicine European public assessment report (EPAR): Desloratadine ratiopharm (updated)

Human medicine European public assessment report (EPAR): Zoledronic acid Mylan (updated)

Human medicine European public assessment report (EPAR): Sildenafil ratiopharm (updated)

Human medicine European public assessment report (EPAR): Imatinib Accord (updated)

Human medicine European public assessment report (EPAR): Myfenax (updated)

Human medicine European public assessment report (EPAR): Lunsumio (updated)

Human medicine European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan (updated)

Human medicine European public assessment report (EPAR): Carvykti (updated)

Human medicine European public assessment report (EPAR): Dimethyl fumarate Polpharma (updated)